Article info
PDFExtended report
Infliximab treatment reduces complement activation in patients with rheumatoid arthritis
- Correspondence to:
MrsA Familian
Department of Immunopathology, Sanquin Research at the CLB, Plesmanlaan 125, 1066 CX Amsterdam, The Netherlands; A.Familiansanquin.nl
Citation
Infliximab treatment reduces complement activation in patients with rheumatoid arthritis
Publication history
- Accepted December 28, 2004
- First published June 15, 2005.
Online issue publication
October 25, 2017
Request permissions
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.
Copyright information
Copyright 2005 by Annals of the Rheumatic Diseases